TCRX stock news · TScan Therapeutics
Get alerts for TCRX
Follow TScan Therapeutics (TCRX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TCRX12 health care stocks changed a lot after the market closed on Tuesday.
NeutralTScan Therapeutics shares fell 5.59%, but the report gives no new company results or business news. The share move alone does not change its business outlook.
12 health care stocks changed a lot during Monday's after-hours trading.
NeutralThe article says TScan Therapeutics shares rose about 9% after hours, but gives no company news explaining the move. The share-price change alone does not change its business outlook.
TScan Therapeutics announced that two directors are leaving and new ones are joining the team.
NeutralTScan Therapeutics reported 2 board departures and updated committee roles. The filing cites no disagreement or change to company operations, so the news does not shift its outlook.
TScan Therapeutics, Inc. says two top leaders are leaving, and new ones are being chosen.
NeutralTScan confirmed planned exits by its finance and medical chiefs and described continued pay and possible milestone awards. The filing does not show a clear change to the company's business outlook.
TScan Therapeutics, Inc. announces the cancellation of a significant definitive agreement (TCRX).
NeutralTScan Therapeutics, Inc. has filed a Form 8-K indicating the termination of a material definitive agreement, which could have significant implications for its business operations and investor confidence. This news is likely to lead to a bearish sentiment in the market as stakeholders assess the potential impacts on the company's future.